BUSCADOR RECOLECTA

Bulwer’s petrel captures from 2007 to 2018 specifying the reproductive performance/status of the individuals (1=unknown reproductive performance, 2=successful breeder, 3=failure at incubation, 4=failure at chick-rearing, 5=non-breeder and 6=breeder with unknown reproductive performance), their colony (Vila or Montaña Clara) and their sex (0=not sexed, 1=male and 2=female). Data from Vila islet in Azores Islands were collected from 2007 to 2012 and in 2016; data from Montaña Clara islet in Canary Islands were collected from 2010 to 2018.

Dades primàries associades a l'article publicat a EClinicalMedicine, vol. 32 [https://doi.org./10.1016/j.eclinm.2020.100720], The trial was conducted in the Pamplona metropolitan area (Navarra, Spain). Patients were enrolled between July 31, 2020 and September 11, 2020 and randomized in a 1:1 ratio to ivermectin (400 mcg/kg) single oral dose or placebo. Assessments on enrollment and at days 4, 7, 14, 21 and 28 post treatment included: general symptoms report, physical examination and adverse events. All patients were asked to complete a daily online diary of symptoms from day 1 to 28 post treatment. On enrollment, as well as on days 7 and 14 blood samples were obtained to assess full blood count, C reactive protein, procalcitonin, ferritin, creatinine phosphokinase, lactic dehydrogenase, troponin T, D dimer, IL-6, and renal function. Viral loads were calculated at enrollment and on days 4, 7, 14 and 21 post treatment based on a nasopharyngeal swab for SARS-CoV-2 PCR (for genes N and E). A semi-quantitative serology for IgG against SARS-CoV-2 was done on samples from all patients on day 21 post-treatment.

Relació d'ajuts concedits a autors de la Universitat de Barcelona per publicar en accés obert durant l'any 2020. Inclou en format CSV el DOI, el títol, els autors, el nom de la revista i l'import concedit.